HKPD - Hong Kong Pharma Digital Ltd Price to Earnings Adjusted for Growth Rate

Corporate company logo of HK Pharma Digital (HKPD)

Hong Kong Pharma Digital (HKPD) minimizes supply chain costs through its online platform and courier services. The P/E dynamics relative to earnings growth visualize this success, with the current mark equal to 0.00. IT solutions for drug authenticity control ensure user trust, while a loyal customer base in Hong Kong making regular repeat medication purchases guarantees a stable revenue stream.

HKPD: Hong Kong Pharma Digital Price/Earnings to Growth Ratio 01/16/2025 - 11/13/2026

Analytical breakdowns for Hong Kong Pharma Digital (HKPD)

- market price and analyst price targets:
Stock Quotes 9zt.hk|HKPD - Consensus Target
- market capitalization statistics:
Market Value HK Pharma Digital|HKPD - Enterprise Value
- shareholders' equity book value data:
Accounting Value of a Share Hong Kong Pharma Digital|HKPD - Company Book Value|Market-to-Book Ratio 9zt.hk|HKPD - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio Hong Kong Pharma Digital|HKPD - Long-Term Debt to Capital|Short-Term Indebtedness to Equity 9zt.hk|HKPD - Company Total Debt|Debt to Net Assets Ratio HK Pharma Digital|HKPD - Company Long-Term Debt|Company Short-Term Debts Hong Kong Pharma Digital|Immediate Liquidity 9zt.hk
- earnings and valuation multiples information:
HKPD - Company Net Income|Net Profit Forecast Hong Kong Pharma Digital|HKPD - P/E Multiple|Forward Price to Earnings Multiple 9zt.hk|HKPD - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation HK Pharma Digital|HKPD - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Hong Kong Pharma Digital|HKPD - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months 9zt.hk|HKPD - Earnings growth in current year|Earnings growth forecast for next year Hong Kong Pharma Digital
- total revenue and sales volume data:
HKPD - Company Revenue|Company Future Revenue 9zt.hk|HKPD - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple HK Pharma Digital
Summary company analytics:Hong Kong Pharma Digital Ltd, HKPD
Manufactured products of 9zt.hk

For Hong Kong Pharma Digital (HKPD), which monetizes the digital transformation of pharmaceutical supply chains in Asia, this indicator compares the asset's current value with the growth dynamics of net profit. By analyzing the weighted PEG ratio, an investor determines the degree of business undervaluation: values below one signal a potential for share price growth that exceeds the issuer's profit growth rate.

Competitors of Hong Kong Pharma Digital

Price/Earnings to Growth Multiple cvshealth.com CVS|McKesson Corp. - Price/Earnings to Growth Multiple|AmerisourceBergen Corporation (COR) - Price to Earnings Adjusted for Growth Rate|Cardinal Health, Inc. - PEG Multiple|Growth-Adjusted Payback Ratio HSIC (henryschein.com)|Prestige Consumer Healthcare, Inc. (PBH) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Wellgistics Health (WGRX)|Price/Earnings to Growth Ratio 111, Inc|Growth-Adjusted P/E Ratio RDGT (Jiuzhou 360)|PEG Multiple UPC|biodexapharma.com (BDRX) - Price to Net Income Growth Ratio|BIMI Holdings - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CJJD|WBA - Price/Earnings to Growth Ratio